Selected article for: "acute respiratory syndrome and BAL fluid"

Author: Bendib, Inès; Beldi-Ferchiou, Asma; Schlemmer, Frédéric; Surenaud, Mathieu; Maitre, Bernard; Plonquet, Anne; Carteaux, Guillaume; Razazi, Keyvan; Godot, Veronique; Hüe, Sophie; Mekontso Dessap, Armand; de Prost, Nicolas
Title: Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS
  • Cord-id: ox2k56q0
  • Document date: 2021_1_9
  • ID: ox2k56q0
    Snippet: BACKGROUND: Biomarkers of disease severity might help individualizing the management of patients with the acute respiratory distress syndrome (ARDS). Whether the alveolar compartmentalization of biomarkers has a clinical significance in patients with pneumonia-related ARDS is unknown. This study aimed at assessing the interrelation of ARDS/sepsis biomarkers in the alveolar and blood compartments and explored their association with clinical outcomes. METHODS: Immunocompetent patients with pneumon
    Document: BACKGROUND: Biomarkers of disease severity might help individualizing the management of patients with the acute respiratory distress syndrome (ARDS). Whether the alveolar compartmentalization of biomarkers has a clinical significance in patients with pneumonia-related ARDS is unknown. This study aimed at assessing the interrelation of ARDS/sepsis biomarkers in the alveolar and blood compartments and explored their association with clinical outcomes. METHODS: Immunocompetent patients with pneumonia-related ARDS admitted between 2014 and 2018 were included in a prospective monocentric study. Bronchoalveolar lavage (BAL) fluid and blood samples were obtained within 48 h of admission. Twenty-two biomarkers were quantified in BAL fluid and serum. HLA-DR(+) monocytes and CD8(+) PD-1(+) lymphocytes were quantified using flow cytometry. The primary clinical endpoint of the study was hospital mortality. Patients undergoing a bronchoscopy as part of routine care were included as controls. RESULTS: Seventy ARDS patients were included. Hospital mortality was 21.4%. The BAL fluid-to-serum ratio of IL-8 was 20 times higher in ARDS patients than in controls (p < 0.0001). ARDS patients with shock had lower BAL fluid-to-serum ratio of IL-1Ra (p = 0.026), IL-6 (p = 0.002), IP-10/CXCL10 (p = 0.024) and IL-10 (p = 0.023) than others. The BAL fluid-to-serum ratio of IL-1Ra was more elevated in hospital survivors than decedents (p = 0.006), even after adjusting for SOFA and driving pressure (p = 0.036). There was no significant association between alveolar or alveolar/blood monocytic HLA-DR or CD8(+) lymphocytes PD-1 expression and hospital mortality. CONCLUSIONS: IL-8 was the most compartmentalized cytokine and lower BAL fluid-to-serum concentration ratios of IL-1Ra were associated with hospital mortality in patients with pneumonia-associated ARDS.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute ards respiratory distress syndrome and adaptive innate immune cell: 1, 2
    • acute ards respiratory distress syndrome and additional file: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and adjusted analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute ards respiratory distress syndrome and adjuvant therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute ards respiratory distress syndrome and admission sofa: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and local lung environment: 1
    • acute ards respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute hypoxemic respiratory failure and additional file: 1, 2
    • acute hypoxemic respiratory failure and adjuvant therapy: 1
    • acute hypoxemic respiratory failure and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8
    • acute physiology ii and adaptive innate: 1
    • acute physiology ii and additional file: 1
    • acute physiology ii and adjusted analysis: 1, 2, 3
    • acute physiology ii and admission sofa: 1, 2, 3, 4, 5, 6
    • adaptive innate and additional file: 1
    • adaptive innate and adjusted analysis: 1
    • adaptive innate and adjuvant therapy: 1, 2
    • additional file and adjuvant therapy: 1, 2, 3